TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 5 | -0 | -2 | 4 | 0 | -6 | 7 | 1 |
| S | %wins | 60 | 60 | 20 | 80 | 60 | 40 | 53 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/29/15 16:30 | 5/27/15 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Jacoby Philip R Jr | MD | O | CFO | S.d | -371 | 18.55 | 3 | -20 | -62 | 13 | D | 64 | 19 | 38 | 8 | 12 | 21 | 5 | 3 | 0 | 1 | 4 | -3 | -43 | -69 |
5/23/14 06:53 | 5/21/14 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Jacoby Philip R Jr | MD | O | CFO | S.d | -246 | 15.43 | 4 | -16 | -56 | 13 | D | 183 | 43 | 5 | -7 | 16 | 9 | 5 | -2 | 3 | -2 | 1 | -10 | -16 | 16 |
11/26/13 06:53 | 11/25/13 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Jacoby Philip R Jr | MD | O | CFO | S.d | -294 | 15.99 | 6 | -18 | -32 | 38 | D | 266 | 71 | 45 | -11 | -11 | 0 | 4 | 13 | 1 | -5 | 0 | -1 | -4 | -17 |
11/5/04 14:06 | 11/3/04 | FCN | Fti Consulting Inc | MD | BizSv | Conslt | Management Consulting Service | Jacoby Philip R Jr | MD | O | VP,Corpo | S.d | -62 | 18.71 | 7 | -3 | -100 | 0 | D | -30 | -5 | 22 | 17 | 2 | 0 | -3 | 3 | -2 | 1 | 6 | -2 | 16 | 52 |
8/9/04 15:47 | 8/9/04 | FCN | Fti Consulting Inc | MD | BizSv | Conslt | Management Consulting Service | Jacoby Philip R Jr | MD | O | VP,Corpo | S | -16 | 16.22 | 12 | -1 | -94 | 0 | D | -36 | -25 | 18 | 4 | 0 | 6 | -11 | -3 | -3 | -3 | 11 | 17 | 15 | 51 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |